Cambridge Investment Research Advisors’s BioNTech BNTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$340K	Buy	3,825 +3	+0.1%	+$308	﹤0.01%	3169
2025 Q4	$364K	Buy	3,822 +52	+1%	+$5.24K	﹤0.01%	3009
2025 Q3	$372K	Sell	3,770 -467	-11%	-$49.9K	﹤0.01%	2936
2025 Q2	$451K	Sell	4,237 -110	-3%	-$11.1K	﹤0.01%	2637
2025 Q1	$396K	Sell	4,347 -14	-0.3%	-$1.57K	﹤0.01%	2648
2024 Q4	$497K	Sell	4,361 -216	-5%	-$24.6K	﹤0.01%	2437
2024 Q3	$544K	Buy	4,577 +154	+3%	+$14.2K	﹤0.01%	2338
2024 Q2	$355K	Sell	4,423 -5	-0.1%	-$457	﹤0.01%	2571
2024 Q1	$409K	Buy	4,428 +719	+19%	+$68.9K	﹤0.01%	2448
2023 Q4	$391K	Sell	3,709 -271	-7%	-$27.3K	﹤0.01%	2395
2023 Q3	$432K	Buy	3,980 +148	+4%	+$16.4K	﹤0.01%	2207
2023 Q2	$414K	Buy	3,832 +655	+21%	+$73.7K	﹤0.01%	2269
2023 Q1	$396K	Sell	3,177 -4,727	-60%	-$649K	﹤0.01%	2259
2022 Q4	$1.19M	Sell	7,904 -171	-2%	-$26.3K	0.01%	1394
2022 Q3	$1.09M	Sell	8,075 -367	-4%	-$56.1K	0.01%	1415
2022 Q2	$1.26M	Sell	8,442 -394	-4%	-$60.2K	0.01%	1308
2022 Q1	$1.51M	Buy	8,836 +1,758	+25%	+$295K	0.01%	1309
2021 Q4	$1.82M	Buy	7,078 +3,492	+97%	+$956K	0.01%	1205
2021 Q3	$979K	Buy	3,586 +159	+5%	+$50.5K	﹤0.01%	1542
2021 Q2	$767K	Sell	3,427 -2,652	-44%	-$500K	﹤0.01%	1738
2021 Q1	$664K	Buy	6,079 +589	+11%	+$62.5K	﹤0.01%	1694
2020 Q4	$448K	Buy	+5,490	New	+$539K	﹤0.01%	1845